Goserelin    (DrugBank: Goserelin)

1 disease
IDDisease name (Link within this page)Number of trials
1Spinal and bulbar muscular atrophy1

1. Spinal and bulbar muscular atrophy    [ 17 clinical trials,   16 drugs,   (DrugBank: 8 drugs),   10 drug target genes,   15 drug target pathways]
Searched query = "Spinal and bulbar muscular atrophy", "Spinobulbar muscular atrophy", "SBMA", "Kennedy disease", "Kennedy-Alter-Sung syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 17 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00851461
(ClinicalTrials.gov)
April 200825/2/2009Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular AtrophyEffect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy in Thai PatientsSpinobulbar Muscular Atrophy;Kennedy's DiseaseDrug: Goserelin;Procedure: Electrophysiologic study;Procedure: tissue biopsyRamathibodi HospitalAstraZenecaCompleted20 YearsN/AMale10Phase 4Thailand